Replies to post #19104 on GTC Biotherapeutics (fka GTCB)

[vinmantoo]

Good job oky. Please be sure to post the response. It is poor management to make deals like the one with the korean firm for insulin and now the Merrimack deal. The former didn't even obtain funds to perform the initial work let alone up front money beyond GTCB's outlays to do the initial studies. The Merrimack deal means they will continue expending money on keeping that herd going, instead of being able to either cut expenditures or divert resources to other projects with more immediate chances for revenue or that don't have the whiff of failure like MM-093. If GTCB had set up a deal for MM-093 that pays upfront money, it owudl be different, but it sounds like typical Cox, we will assemble more projects and spreading ourselves thin because some day the sun will shine.